Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.
2.

Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?

Abraham PF, Calabrese JR.

J Affect Disord. 2008 Nov;111(1):21-30. doi: 10.1016/j.jad.2008.01.024. Epub 2008 Mar 4. Review.

PMID:
18304647
3.

Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Bellino S, Paradiso E, Bogetto F.

CNS Drugs. 2008;22(8):671-92. Review.

PMID:
18601305
4.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
5.

Psychopharmacology of borderline personality disorder.

Raj YP.

Curr Psychiatry Rep. 2004 Jun;6(3):225-31. Review.

PMID:
15142476
6.

Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.

Mercer D, Douglass AB, Links PS.

J Pers Disord. 2009 Apr;23(2):156-74. doi: 10.1521/pedi.2009.23.2.156. Review.

PMID:
19379093
7.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
8.

Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials.

Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM.

Br J Psychiatry. 2010 Jan;196(1):4-12. doi: 10.1192/bjp.bp.108.062984. Review.

9.
10.

Impulsive aggression in borderline personality disorder.

Goodman M, New A.

Curr Psychiatry Rep. 2000 Feb;2(1):56-61. Review.

PMID:
11122933
11.

Aggression in borderline personality disorder.

Látalová K, Prasko J.

Psychiatr Q. 2010 Sep;81(3):239-51. doi: 10.1007/s11126-010-9133-3. Review.

PMID:
20390357
12.

[Drug therapy of patients with emotionally unstable personality].

Nissen T.

Tidsskr Nor Laegeforen. 2000 Aug 10;120(18):2135-41. Review. Norwegian.

PMID:
11006733
13.

Update on pharmacotherapy of borderline personality disorder.

Zanarini MC.

Curr Psychiatry Rep. 2004 Feb;6(1):66-70. Review.

PMID:
14738708
14.

Personality trait dimensions and the pharmacological treatment of borderline personality disorder.

Saunders EF, Silk KR.

J Clin Psychopharmacol. 2009 Oct;29(5):461-7. doi: 10.1097/JCP.0b013e3181b2b9f3. Review.

PMID:
19745646
15.

Medications in the treatment of borderline personality disorder 2006.

Mercer D.

Curr Psychiatry Rep. 2007 Feb;9(1):53-62. Review.

PMID:
17257515
16.

Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.

Kolevzon A, Mathewson KA, Hollander E.

J Clin Psychiatry. 2006 Mar;67(3):407-14. Review.

PMID:
16649827
17.

State of the art in the pharmacologic treatment of borderline personality disorder.

Feurino L 3rd, Silk KR.

Curr Psychiatry Rep. 2011 Feb;13(1):69-75. doi: 10.1007/s11920-010-0168-9. Review.

PMID:
21140245
18.

Pharmacotherapy of borderline personality disorder.

Hirschfeld RM.

J Clin Psychiatry. 1997;58 Suppl 14:48-52; discussion 53. Review.

PMID:
9418746
19.

Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose.

Bellino S, Rinaldi C, Bozzatello P, Bogetto F.

Curr Med Chem. 2011;18(22):3322-9. Review.

PMID:
21728970
20.

[Symptom-focussed drug therapy in borderline personality disorder].

Schmahl C, Bohus M.

Fortschr Neurol Psychiatr. 2001 Jul;69(7):310-21. Review. German.

PMID:
11488246
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk